Cargando…
COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus
This review describes the incidence, epidemiology, and risk factors for mortality of COVID-19 in immunocompromised patients, including persons with human immunodeficiency virus. It describes various preventive measures, including vaccines and their effectiveness and the role of monoclonal antibodies...
Autores principales: | Jakharia, Niyati, Subramanian, Aruna K., Shapiro, Adrienne E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806148/ https://www.ncbi.nlm.nih.gov/pubmed/35636907 http://dx.doi.org/10.1016/j.idc.2022.01.006 |
Ejemplares similares
-
Viruses Including Human Immunodeficiency Virus
por: Wanger, Audrey, et al.
Publicado: (2017) -
1562. Impact of Skin Biopsy on Diagnosing Infections and Changing Treatment in Cancer Patients with New Skin Rash
por: Jakharia, Niyati, et al.
Publicado: (2018) -
CMV Infection in Hematopoietic Stem Cell Transplantation: Prevention and Treatment Strategies
por: Jakharia, Niyati, et al.
Publicado: (2021) -
Human parvovirus B19 infection in an immunocompromised host
por: Pandey, Soumya
Publicado: (2020) -
440. Necrotizing Soft-Tissue Infections Involving Actinomyces Species
por: Jakharia, Niyati, et al.
Publicado: (2019)